Genmab - Latest News and Information
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Technology Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
HomeGenmab
Genmab logo

Genmab

0 followers

GMAB

Performance

About Genmab

Genmab is an international biotechnology company focused on creating and developing antibody therapeutics to treat cancer and other serious diseases. The company emphasizes pioneering antibody science and proprietary technologies to advance next-generation medicines, with a global presence including regional sites in Japan and the United States. Genmab emphasizes collaborations with healthcare professionals, patients, and partners to transform patient outcomes and drive innovation in oncology and related fields. Its mission includes incorporating patient perspectives and sustainable practices across its research, development, and corporate activities.

Recent News

Recent Deals

No recent deals for this company.

Key Team Members

Jan G. J. van de Winkel

President & CEO

Birgitte Stephensen

Executive Vice President & Chief Legal Officer

Anthony Pagano

EVP & CFO

Christopher Cozic

EVP & CPO

Judith Klimovsky

Chief Development Officer

Key Facts

HQ Location

Copenhagen, Denmark

Founded

1999

Employees

1K-5K

Status

Public

Website

https://genmab.com